Study of mast cells in autoinflammatory diseases
Part of Genetic & congenital, Immune system & allergy, Skin clinical trials.
This study looks at whether “mast cells” (a type of immune cell involved in inflammation) play a role in autoinflammatory diseases. It compares people with autoinflammatory conditions to healthy controls and people with mastocytosis, to better understand disease mechanisms and potential targets.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be over 18 years old
- Have an autoinflammatory disease and already be followed at the CeRéMAIA center at Tenon Hospital (and in the JIR cohort), or be a matched control
- If you’re part of the control group: be age- and sex-matched to the main patient group, including people with mastocytosis
- Be able to speak and understand French well enough to answer questions
- Agree to have your data and/or samples used by signing a “non-opposition” (no objection)
- Not be unable to communicate, and not be in a situation where you’re not free to decide (for example, deprived of liberty or under legal protection)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at blood “biomarkers,” or measurable body signals, in people with autoimmune diseases, vasculitis, or autoinflammatory conditions. The goal is to better understand these illnesses and how they relate to disease activity.
This study looks for genetic causes of hard-to-diagnose autoinflammatory diseases or a related condition called AA amyloidosis. It aims to find answers for people whose condition does not fit any known type, by studying their genes and medical history.
This study is for people with certain rheumatic conditions (like arthritis, lupus, or vasculitis) and for healthy volunteers. It aims to learn more about these diseases and improve how they are treated.
This study looks at how the immune system works in people with rare autoinflammatory diseases. The goal is to develop tests that can help doctors better understand and treat these conditions.
This study measures blood “biomarkers” (signals in blood) to better understand inflammatory diseases, including autoimmune and autoinflammatory conditions. You may be asked to give blood samples now and possibly extra samples if needed for testing.
This study looks at the gut bacteria (microbiome) in people with autoinflammatory diseases. It may help researchers understand how bacteria in the gut affect inflammation and find better ways to treat these conditions.
Hear when a new Autoinflammatory Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.